BTSG BrightSpring Health Services, Inc.

BTSG financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1865782 Exchange: Nasdaq SIC: 8082 (Services-Home Health Care Services) Latest filing: 10-Q filed Jul 31, 2026 Data checked: Oct 21, 2026
Showing 3 of 4 annual and 0 of 14 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Large accelerated filer
Entity Type
Operating
Public Float
$2.35B (Jun 2025)
Industry (SIC)
8082 Services-Home Health Care Services
Incorporated
DE
Fiscal Year End
December (1231)
Phone
502-394-2100
EIN
822956404
Headquarters
LOUISVILLE, KY, 40222
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
$14.37B
Net Income
$365.97M
Total Assets
$5.99B
Total Equity
$2.05B
Total Debt
$2.19B
Free Cash Flow
$402.35M
Ratios
Gross Margin
12.4%
Operating Margin
3.1%
Net Margin
2.5%
Return on Equity
17.9%
Return on Assets
6.1%
Current Ratio
1.59x
Debt / Equity
1.07x
FCF / Assets
6.7%

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

Fiscal 2025 results for BrightSpring Health Services, Inc. combined $12.91B of revenue with net income of $190.67M and an operating cash inflow of $490.17M. Revenue of $12.91B sets the scale for evaluating how effectively sales translated into profit and cash during the year. Revenue was 28.2% above fiscal 2024 revenue of $10.07B, marking a year-over-year increase. The company reported diluted EPS of $0.87, adding a shareholder-level measure to the absolute income figures considered below. Revenue equaled 2.01x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

Gross profit was $1.52B, representing the portion of revenue remaining after the reported cost of revenue and before operating expenses. Gross profit represented 11.8% of revenue, showing how much of the top line remained after direct costs. Operations produced $295.25M of income after the reported operating expense base, before the remaining non-operating and tax effects. Operating margin measured 2.3%, showing the portion of revenue preserved after the full set of operating costs. Net income came to $190.67M, completing the progression from revenue through gross and operating profitability to the final reported result. Net margin was 1.5%, meaning that this portion of revenue remained as net income after all recognized expenses. The earnings statement records $137.94M of pretax income, the profit base against which the reported tax provision can be assessed. The pretax margin was 1.1%, relating income before taxes directly to revenue. Income tax expense totaled $33.15M, providing the reported tax component that separates pretax and after-tax earnings. The income-tax provision equaled 24.0% of pretax income, showing the tax burden absorbed by the year’s earnings.

Liquidity and Capital Structure

At period end, the $6.41B asset base was financed through $4.53B of liabilities and $1.88B of equity. Current assets were $2.89B against $1.85B of current liabilities, framing the resources and obligations classified within the near-term balance-sheet horizon. At 1.57x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. Cash and equivalents totaled $88.37M, identifying the most liquid reported component available within the broader current-asset balance. Cash and equivalents represented 4.8% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. Total debt was $2.51B, establishing the amount of borrowing carried within the company’s capital structure. Debt equaled 1.34x of book equity, describing the relative scale of borrowing and shareholder capital. The debt-to-assets relationship was 39.1%, comparing borrowing with the total asset balance. Liabilities represented 70.6% of total assets, quantifying the liability-funded share of the company’s resource base. Measured against total assets, cash and equivalents represented 1.4%, a balance-sheet composition measure rather than a liquidity forecast. The asset base changed 8.2% from $5.93B in fiscal 2024, leaving current total assets higher year over year.

Cash Flow and Earnings Quality

The company reported $490.17M of operating cash flow, a cash inflow that shows the cash generated by operations. Against net income, operating cash flow measured 2.57x, showing the relationship between accrual earnings and operating cash. Capital spending was $95.48M, absorbing part of the cash generated from operations before free cash flow. Capital expenditures represented 19.5% of operating cash flow, leaving the remainder available as free cash flow. The combination of operating cash flow and capital spending produced $394.69M of positive free cash flow for the period. The free-cash-flow margin was 3.1%, measuring cash remaining after capital spending against revenue. Free cash flow equaled 6.2% of total assets, relating post-investment cash generation to the company’s resource base.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for BrightSpring Health Services, Inc.
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $12.91B $10.07B $7.69B
Gross Profit $1.52B $1.27B $1.14B
OPERATING EXPENSES
SG&A Expense $1.22B $1.16B $1.08B
Operating Income $295.25M $107.95M $58.13M
NON-OPERATING INCOME / EXPENSE
Interest Expense $157.31M $190.55M $271.90M
Pretax Income $137.94M $-95.32M $-213.77M
Income Tax $33.15M $-26.39M $-31.51M
Net Income $190.67M $-18.06M $-154.60M
PER SHARE & SUPPLEMENTAL
Diluted EPS $0.87 $-0.09 $-1.31
Diluted Shares 219.77M 193.00M 117.87M
EBITDA $459.53M $312.44M $260.46M
Depreciation & Amortization $164.28M $204.48M $202.34M
Balance Sheet
ASSETS
Cash & Equivalents $88.37M $60.95M $13.07M
Accounts Receivable $989.72M $902.78M $881.63M
Inventory $815.18M $636.56M $402.78M
Other Current Assets $118.59M $161.31M $159.17M
Current Assets $2.89B $1.89B $1.46B
PP&E (Net) $204.69M $180.57M $245.91M
Goodwill $2.55B $2.36B $2.61B
Intangible Assets $557.56M $595.22M $881.48M
Other Noncurrent Assets $39.71M $39.13M $72.84M
Noncurrent Assets $3.52B $4.03B $4.08B
Total Assets $6.41B $5.93B $5.53B
LIABILITIES
Accounts Payable $1.22B $923.93M $641.61M
Short-term Debt $52.34M $48.73M $32.27M
Other Current Liabilities $44.78M $32.96M $40.83M
Current Liabilities $1.85B $1.43B $1.25B
Long-term Debt $2.46B $2.56B $3.33B
Other Noncurrent Liabilities $707.00K $6.59M $5.34M
Noncurrent Liabilities $2.68B $2.85B $3.67B
Total Liabilities $4.53B $4.27B $4.92B
EQUITY
Common Stock $1.92M $1.74M $1.18M
Additional Paid-in Capital $1.95B $1.87B $771.34M
Retained Earnings $-74.65M $-222.16M $-200.32M
Accumulated OCI $-6.69M $1.42M $12.54M
Total Equity $1.88B $1.65B $585.41M
Temporary Equity $11.23M $3.73M $27.14M
Total Liabilities & Equity $6.41B $5.93B $5.53B
SUPPLEMENTAL
Total Debt $2.51B $2.61B $3.36B
Shares Outstanding 192.12M 174.25M 117.86M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $490.17M $23.77M $210.78M
Capital Expenditures $95.48M $80.91M $73.53M
Cash from Investing $-305.08M $-140.24M $-134.43M
Cash from Financing $-157.87M $164.65M $-76.91M
Free Cash Flow $394.69M $-57.14M $137.26M
Beginning Cash (CFS) $60.95M $13.07M $13.63M
Net Change in Cash $27.22M $48.18M $-557.00K
Effect of FX on Cash - - -
Calculated Ending Cash $88.18M $61.25M $13.07M
Cash per BS $88.37M $60.95M $13.07M
Cash scope difference (CFS − BS) - $299.00K -
Cash per CFS $88.37M $61.25M $13.07M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is BrightSpring Health Services, Inc.'s annual revenue?

BrightSpring Health Services, Inc. reported $14.37B in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is BrightSpring Health Services, Inc. profitable?

Yes. BrightSpring Health Services, Inc. reported $365.97M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.

What is BrightSpring Health Services, Inc.'s debt level?

BrightSpring Health Services, Inc. carries $2.19B in total debt as of trailing twelve months. Total shareholders' equity stands at $2.05B.

Does BrightSpring Health Services, Inc. generate free cash flow?

Yes. Free cash flow was $402.35M for trailing twelve months. Operating cash flow was $506.35M.